Helsinn Holding SA, a privately-owned pharmaceutical company, is to establish a centre of excellence in R&D of oral solid dosage at its existing site in Dublin.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.